Jiangxi Fushine Pharmaceutical (300497.SZ) plans to raise no more than 700 million yuan through a private placement of shares.

21:18 31/07/2026

Fuxiang Co., Ltd. (300497.SZ) has released a plan for the issuance of A-shares to specific targets for the year 2026, with the total amount of funds raised not exceeding RMB 700 million (including this amount). The net amount of the raised funds, after deducting the relevant issuance expenses, will be used for the following projects: a project for an annual production of 20,000 tons of fluoroethyl carbonate (FEC), a high-quality triazole project, and to supplement working capital.

Jiangxi Fushine Pharmaceutical (300497.SZ) announced its plan to issue A-shares to specific targets in 2026, with a total fundraising amount not exceeding 700 million RMB (inclusive). The net proceeds from this issuance, after deducting the related issuance costs, will be used for the following projects: an annual production of 20,000 tons of fluoroethyl carbonate (FEC) project, a high-quality triazole project, and supplementing working capital.

HK Stock Market Move | LEGEND HOLDING (03396) rose over 6% following a positive earnings forecast, expecting a net profit attributable to equity holders in the first half to increase by no less than 186% year-on-year.

HK Stock Market Move | XUNCE (03317) surged over 18% as revenue driven by its token business significantly increased,.

HK Stock Market Move | TAI HING GROUP (06811) rose over 8% after announcing a profit alert, expecting a net profit attributable to shareholders of approximately HKD 72 million to HKD 78 million for the first half of the year.

HK Stock Market Move | XUNCE (03317) surged over 18% as revenue driven by its token business significantly increased,.